Summary

● The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.


Strengths

● Thanks to a sound financial situation, the firm has significant leeway for investment.

● Historically, the company has been releasing figures that are above expectations.

● The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.5 for the 2020 fiscal year.

● Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.


Weaknesses

● Technically, the stock approaches a strong medium-term resistance at USD 15.71.

● As estimated by analysts, this group is among those businesses with the lowest growth prospects.

● Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.

● The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 46.75 times its estimated earnings per share for the ongoing year.

● For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.

● For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.

● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.